Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Anemia × neratinib × Clear all

Sponsor

Conditions

Breast Neoplasms 19 Neoplasms 6 Neoplasm Metastasis 3 Advanced Malignant Solid Tumors 3 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Inflammatory Breast Neoplasms 1 HER2+ Metastatic Breast Cancer (MBC) 1

Interventions

Epoetin Alfa 7 Darbepoetin alfa 5 epoetin beta 4 Cyclophosphamide 4 ACE-011 4 fludarabine 3 Busulfan 3 thymoglobulin 2 luspatercept 2 fludarabine phosphate 2 Lenalidomide 2 Cyclosporine 2 Antilymphocyte Serum 2 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2 vactosertib 1 telapristone acetate 1 ruxolitinib 1 roxadustat 1 obinutuzumab 1 ibrutinib 1 fosphenytoin 1 ferrous sulfate 1 ferric gluconate 1 ferric carboxymaltose 1 Whole-Body Irradiation 1 Thiotepa 1 Therapeutics 1 Surveys and Questionnaires 1 Sugars 1 Sucrose 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡